Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

334

HTML

2065

Figures (1-2)

186

Tables (1-4)

215

Sum=2800

Jun 15, 2004 (publication date) through Oct 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jun 15, 2004; 10(12): 1722-1725
Published online Jun 15, 2004. doi: 10.3748/wjg.v10.i12.1722

Table 2 Flow cytometric analysis of Bcl-2 and Bax expression in human gastric cancer cell line SGC7901 and its drug-resistant counterpart SGC7901/VCR

^aP < 0.05 vs SGC7901 cell line.

Citation: Li DQ, Wang ZB, Bai J, Zhao J, Wang Y, Hu K, Du YH. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone. World J Gastroenterol 2004; 10(12): 1722-1725
URL: https://www.wjgnet.com/1007-9327/full/v10/i12/1722.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i12.1722